Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Mayo Clinic

Status: Enrolling

Conditions: Colorectal Carcinoma

Treatments: Behavioral: Patient Navigation; Other: Fecal Immunochemical Test; Other: Questionnaire Administration; Other: Educational Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05447923

NCI-2022-04529 (Registry Identifier)

21-009729 (Other Identifier)

FIT DOM (Other Identifier)

Details and patient eligibility

About

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Full description

PRIMARY OBJECTIVES:

I. To evaluate patient navigation to address colorectal cancer disparities seen in people of color, minority populations, and establish an ongoing colorectal cancer screening outreach program for this community in Phoenix.

OUTLINE:

Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results.

After completion of screening, participants with a positive FIT test are followed up at 2 and 4 weeks after initial outreach to assure participants have received adequate follow up.

Enrollment: 450 estimated patients

Sex: All

Ages: 45+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age 45 years of age or older
• No prior history of colorectal cancer or colon polyps
• No first-degree family history of colorectal cancer who were diagnosed under age 60
• No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
• Have not undergone a colonoscopy in the last 5 years
• Have not had a fecal immunochemical test (FIT) test within the last year
• Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

450 participants in 1 patient group

Screening (FIT, education, questionnaire, patient navigation)

Experimental group

Description:

Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results.

Treatment:

Other: Educational Intervention

Other: Questionnaire Administration

Other: Fecal Immunochemical Test

Behavioral: Patient Navigation